Newsfeeds - Spark Newswire

1 minute read

Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer

Today, 7:48 AM

Zymeworks Inc (NASDAQ:ZYME) announced topline results from the pivotal Phase 2b HERIZON-BTC-01 trial investigating zanidatamab as monotherapy in patients with previously…

BGNE

1 minute read

SVB Leerink Maintains Outperform on BeiGene, Raises Price Target to $236

By Benzinga Newsdesk

Today, 7:48 AM

SVB Leerink analyst Andrew Berens maintains BeiGene (NASDAQ:BGNE) with a Outperform and raises the price target from $210 to $236.

BGNE

2 minute read

Will Investors Notice Exciting Sign On BeiGene’s Chart?

By Benzinga Insights

Today, 7:48 AM

If history is any guide, there may be good fortune ahead for shares of BeiGene (NASDAQ:BGNE). A so-called…

BGNE

4 minute read

Why Leslie’s Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 7:48 AM

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

AGLE

2 minute read

Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

Today, 7:48 AM

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

API

2 minute read

Dollar Tree, Dycom Industries, Chico’s FAS And Other Big Losers From Tuesday

By Lisa Levin

Today, 7:48 AM

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

AGBA

1 minute read

BeiGene Announces Brazil Approvals For BRUKINSA As A Treatment For Rare Blood Cancers

By Benzinga Newsdesk

Today, 7:48 AM

BeiGene, (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)), a global biotechnology, today announced BRUKINSA (zanubrutinib) has been approved in Brazil for the treatment of adult patients with Waldenström’s

BGNE

2 minute read

Tesla, Amazon, Coupang, Rivian, Beigene: Musk’s Share Sale, Antitrust Lawsuit, Earnings Grab Retail Investors’ Eyeballs

By Bhavik Nair

Today, 7:48 AM

Major Wall Street indices closed nearly 2% lower on Wednesday after the day was marred by uncertainties including the outcome of the mid-term elections and a sell-off in the cryptocurrency market. Binance

AAPL

1 minute read

Jazz Obtains Exclusive Rights To Zymeworks’ Cancer Candidate In Almost $2B Biobuck Deal

By Vandana Singh

Today, 7:48 AM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) will acquire development and commercialization rights to Zymeworks Inc’s (NASDAQ:ZYME) zanidatamab across all indications in the U.S., Europe, Japan,…

BGNE

1 minute read

FDA
News

BeiGene Receives Positive CHMP Opinion For BRUKINSA (zanubrutinib) For Treatment Of Adults With CLL

By Benzinga Newsdesk

Today, 7:48 AM

BeiGene (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)))), a global biotechnology company focused on developing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide, today

BGNE